By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurocrine Biosciences, Inc. 

12790 El Camino Real

San Diego  California  92121  U.S.A.
Phone: 858-617-7600 Fax: 858-617-7601


SEARCH JOBS








Company News
Neurocrine Biosciences (NBIX) Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Children And Adolescents With Tourette Syndrome 2/2/2016 6:45:00 AM
Neurocrine Biosciences (NBIX) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 7:48:36 AM
Neurocrine Biosciences (NBIX) Announces Successful Completion Of Phase Ib T-Force Study Of VMAT2 Inhibitor NBI-98854 In Adolescents And Children With Tourette Syndrome 12/17/2015 6:35:43 AM
Neurocrine Biosciences (NBIX) To Present At The 27th Annual Piper Jaffray Healthcare Conference 11/25/2015 11:18:20 AM
Neurocrine Biosciences (NBIX) To Present At Credit Suisse's 24th Annual Healthcare Conference 11/5/2015 10:06:57 AM
Neurocrine Biosciences (NBIX) Announces Expansion Of Its Clinical Pipeline 11/4/2015 6:47:03 AM
Neurocrine Biosciences (NBIX) Announces Conference Call And Webcast To Report Third Quarter 2015 Results 10/23/2015 10:37:50 AM
Neurocrine Biosciences (NBIX) Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor NBI-98854 In Adults With Tourette Syndrome 10/20/2015 8:25:00 AM
Neurocrine Biosciences (NBIX)'s NBI-98854 Hits Primary Enpoint in Phase III Study 10/8/2015 5:52:55 AM
Neurocrine Biosciences (NBIX) To Present At The Jefferies Autumn 2015 Global Healthcare Conference 10/5/2015 9:17:36 AM
12345678910...
//-->